MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 157 filers reported holding MERSANA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | -61.9% | 12,679 | 0.0% | 0.00% | – |
| Q2 2023 | $42 | +7.7% | 12,679 | +35.0% | 0.00% | – |
| Q1 2023 | $39 | -43.5% | 9,391 | -20.5% | 0.00% | -100.0% |
| Q4 2022 | $69 | -99.9% | 11,816 | +3.2% | 0.00% | 0.0% |
| Q3 2022 | $77,000 | +51.0% | 11,451 | +2.8% | 0.00% | – |
| Q2 2022 | $51,000 | +18.6% | 11,135 | +3.2% | 0.00% | – |
| Q1 2022 | $43,000 | -70.1% | 10,790 | -53.6% | 0.00% | -100.0% |
| Q4 2021 | $144,000 | +28.6% | 23,272 | +96.4% | 0.00% | 0.0% |
| Q3 2021 | $112,000 | -31.3% | 11,850 | -1.4% | 0.00% | 0.0% |
| Q2 2021 | $163,000 | -26.6% | 12,021 | +44.4% | 0.00% | -87.5% |
| Q4 2020 | $222,000 | – | 8,324 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |